- 1
clinical study ongoing
in patients - 7
clinical trials
completed - 679
people enrolled so far in phase 1 and phase 2
clinical trials - 496
people exposed to DAV132
We are currently conducting the following clinical study:
| Study | Phase | Objectives | Links |
|---|---|---|---|
| MICROCARE | Phase 3 | A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in patients with newly-diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy. |
The following clinical trials have been completed:
| Study | Phase | Objectives | Links |
|---|---|---|---|
| DAV132-CL-2001 SHIELD Study | Phase 2 | Evaluate the safety and efficacy of DAV132 during fluoroquinolones treatment in hospitalized elderly patients with comorbidities | ClinicalTrials.gov Press Release |
| DAV132-CL-1006 | Phase 1 | Evaluate the safety and efficacy of DAV132 during 5 days of IV 𝛃-Lactam treatments | |
| DAV132-CL-1004 | Phase 1 | Evaluate the safety and efficacy of different regimens of DAV132 with moxifloxacin as a model antibiotic | ClinicalTrials.gov Poster |
| DAV132-CL-1003 DAV132-CL-1005 | Phase 1 | Drug-drug interaction study to characterized the influence of DAV132 on pharmacokinetic parameters of concomitant drugs | Press Release Article |
| DAV132-CL-1002 | Phase 1 | Evaluate the safety and efficacy of DAV132 during 5 days of oral moxifloxacin treatment | ClinicalTrials.gov Poster Article |
| DAV132-CL-1001 | Phase 1 | Validate the mode of action of the colon-targeted release | Poster Article |
